middle.news
Amplia Therapeutics Surges Ahead with ACCENT Trial Recruitment Completion
6:29pm on Sunday 1st of June, 2025 AEST
•
Pharmaceuticals
Read Story
Amplia Therapeutics Surges Ahead with ACCENT Trial Recruitment Completion
6:29pm on Sunday 1st of June, 2025 AEST
Key Points
ACCENT Phase 2a trial recruitment completed ahead of schedule
10 confirmed partial responses recorded among 53 patients
Median duration on trial improved by 68% over historical data
Top-line data expected mid-Q3 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Amplia Therapeutics (ASX:ATX)
OPEN ARTICLE